139 related articles for article (PubMed ID: 6521857)
21. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Rouillard C; Bédard P; Falardeau P; Di Paolo T
Eur J Pharmacol; 1988 Nov; 157(2-3):125-33. PubMed ID: 2975996
[TBL] [Abstract][Full Text] [Related]
22. Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
Rouillard C; Bédard PJ; Falardeau P; Dipaolo T
Neuropharmacology; 1987 Nov; 26(11):1601-6. PubMed ID: 3431663
[TBL] [Abstract][Full Text] [Related]
23. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra.
Olds ME; Jacques DB; Kopyov O
Synapse; 2003 May; 48(2):90-9. PubMed ID: 12619043
[TBL] [Abstract][Full Text] [Related]
24. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
[TBL] [Abstract][Full Text] [Related]
25. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
Neve KA; Kozlowski MR; Marshall JF
Brain Res; 1982 Jul; 244(1):33-44. PubMed ID: 6288182
[TBL] [Abstract][Full Text] [Related]
26. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat.
Kelly E; Jenner P; Marsden CD
Exp Brain Res; 1984; 55(2):243-52. PubMed ID: 6611272
[TBL] [Abstract][Full Text] [Related]
27. Evidence that striatal efferents relate to different dopamine receptors.
Herrera-Marschitz M; Ungerstedt U
Brain Res; 1984 Dec; 323(2):269-78. PubMed ID: 6525513
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
29. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
30. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
31. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
32. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
Costall B; Naylor RJ; Pycock C
Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
[TBL] [Abstract][Full Text] [Related]
33. The influence of unilateral 6-OH-dopamine lesions of the substantia nigra in the absence of the telencephalon.
Papadopoulos G; Huston JP; Nef B
Brain Res Bull; 1981 Feb; 6(2):165-70. PubMed ID: 7470960
[TBL] [Abstract][Full Text] [Related]
34. Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine.
Gruenthal M
Brain Res; 1984 Jul; 306(1-2):189-96. PubMed ID: 6432217
[TBL] [Abstract][Full Text] [Related]
35. Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions.
Starr MS; Summerhayes M
Neuroscience; 1983 Dec; 10(4):1171-83. PubMed ID: 6320047
[TBL] [Abstract][Full Text] [Related]
36. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
37. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
38. Morphine dependence and dopaminergic activity: tests of circling responses in rats with unilateral nigral lesions.
Halliwell JV; Kumar R
Br J Pharmacol; 1980 Dec; 70(4):545-54. PubMed ID: 6258680
[TBL] [Abstract][Full Text] [Related]
39. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
40. Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra.
Freed WJ; Ko GN; Niehoff DL; Kuhar MJ; Hoffer BJ; Olson L; Cannon-Spoor HE; Morihisa JM; Wyatt RJ
Science; 1983 Nov; 222(4626):937-9. PubMed ID: 6635666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
